A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This is a First in Human study to assess the safety and tolerability of AZD7624, following
inhaled administration of single ascending doses in healthy male volunteers and female
volunteers of non-child bearing potential. Pharmacokinetics (what the body does to the drug)
and pharmacodynamic (what the drug does to the body) parameters will be also assessed as
secondary objectives.